J&J to ship children's medicine amid House committee hearing

WASHINGTON Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of its children's medicines following a nationwide recall.

J&J CEO William Weldon said nearly 1 million bottles of the medicine -- which he did not disclose -- will be available for release next week. The drug maker met with the House Committee on Oversight and Government Reform on Thursday to examine the circumstances surrounding J&J’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.

On Sept. 16, J&J's consumer group chair Colleen Goggins said she would retire from her post on March 1, 2011.

Recommended stories

Login or Register to post a comment.